| |
 |
|
Class Information
Number: 424/191.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from parasitic organism (e.g., dirofilaria, eimeria, trichinella, etc.)
Description: Subject matter wherein the disclosed amino acid sequence is derived from a protein or fragment thereof of a parasitic organism.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7354594 |
Merozoite surface protein 1 lacking glycosylation sites |
Apr. 8, 2008 |
| 7335736 |
Compositions and methods for detecting Treponema palidum |
Feb. 26, 2008 |
| 7335733 |
Tissue cement proteins from Rhipicephalus appendiculatus |
Feb. 26, 2008 |
| 7306806 |
Recombinant P. falciparum merozoite protein-142 vaccine |
Dec. 11, 2007 |
| 7303751 |
Anti-plasmodium compositions and methods of use |
Dec. 4, 2007 |
| 7303752 |
Hookworm vaccine |
Dec. 4, 2007 |
| 7264812 |
Ostertagia vaccine |
Sep. 4, 2007 |
| 7256281 |
Recombinant P. falciparum merozoite protein-1.sub.42 vaccine |
Aug. 14, 2007 |
| 7166693 |
Ectoparasite saliva proteins |
Jan. 23, 2007 |
| 7150875 |
Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine |
Dec. 19, 2006 |
| 7125958 |
Malaria polypeptides |
Oct. 24, 2006 |
| 7094391 |
Compositions and methods for administering Borrelia burgdorferi antigens |
Aug. 22, 2006 |
| 7090849 |
Babesia canis vaccine |
Aug. 15, 2006 |
| 7087231 |
Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
Aug. 8, 2006 |
| 7078043 |
Malaria vaccine |
Jul. 18, 2006 |
| 7071296 |
Plasmodium falciparum antigens inducing protective antibodies |
Jul. 4, 2006 |
| 7067639 |
Method to provide bacterial ghosts provided with antigens |
Jun. 27, 2006 |
| 7056518 |
Malarial pre-erythrocytic stage polypeptide molecules |
Jun. 6, 2006 |
| 6979451 |
Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use |
Dec. 27, 2005 |
| 6969602 |
Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protection with other Eimeria maximas |
Nov. 29, 2005 |
| 6958235 |
Recombinant protein containing a C-terminal fragment of plasmodium MSP-1 |
Oct. 25, 2005 |
| 6942858 |
Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
Sep. 13, 2005 |
| 6939549 |
Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use |
Sep. 6, 2005 |
| 6936263 |
Th1 inducing natural adjuvant for heterologous antigens |
Aug. 30, 2005 |
| 6911208 |
Antigenic protein originating in malassezia |
Jun. 28, 2005 |
| 6900049 |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
May. 31, 2005 |
| 6893640 |
Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
May. 17, 2005 |
| 6890536 |
Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications |
May. 10, 2005 |
| 6855323 |
Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
Feb. 15, 2005 |
| 6855322 |
Isolation and purification of P. falciparum merozoite protein-142 vaccine |
Feb. 15, 2005 |
| 6855319 |
Gene encoding merozoite protein of Babesia caballi, recombinant protein obtained therefrom and utilization thereof |
Feb. 15, 2005 |
| 6828416 |
Recombinant multivalent malarial vaccine against Plasmodium falciparum |
Dec. 7, 2004 |
| 6815183 |
Plasmodium sp. chitinase |
Nov. 9, 2004 |
| 6808714 |
Detection of sarcocystis neurona |
Oct. 26, 2004 |
| 6780417 |
Transmission blocking immunogen from malaria |
Aug. 24, 2004 |
| 6773712 |
Parasitic helminth cuticlin proteins and uses thereof |
Aug. 10, 2004 |
| 6774120 |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
Aug. 10, 2004 |
| 6759048 |
Neutralization-sensitive epitopes of Cryptosporidium parvum |
Jul. 6, 2004 |
| 6723322 |
Angiogenic Onchocerca volvulus proteins and uses thereof |
Apr. 20, 2004 |
| 6719975 |
Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
Apr. 13, 2004 |
| 6710166 |
41 kDa Cryptosporidium parvum oocyst wall protein |
Mar. 23, 2004 |
| 6709661 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Mar. 23, 2004 |
| 6680182 |
Expression of recombinant fusion proteins in attenuated bacteria |
Jan. 20, 2004 |
| 6680061 |
Coccidiosis vaccines |
Jan. 20, 2004 |
| 6676944 |
Vaccine containing a peroxiredoxin and/or a .beta.-tubulin |
Jan. 13, 2004 |
| 6673351 |
Compositions and methods for the treatment and clinical remission of psoriasis |
Jan. 6, 2004 |
| 6669945 |
Universal T-cell epitopes for anti-malarial vaccines |
Dec. 30, 2003 |
| 6660269 |
Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
Dec. 9, 2003 |
| 6641816 |
Use of poxviruses as enhancer of specific immunity |
Nov. 4, 2003 |
| 6641815 |
Sequestrin |
Nov. 4, 2003 |
|
|
|
